Yuetong Chen

1.2k total citations · 1 hit paper
53 papers, 809 citations indexed

About

Yuetong Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuetong Chen has authored 53 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Yuetong Chen's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers) and Ferroptosis and cancer prognosis (5 papers). Yuetong Chen is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers) and Ferroptosis and cancer prognosis (5 papers). Yuetong Chen collaborates with scholars based in China, Japan and United States. Yuetong Chen's co-authors include Yanrong Zhang, Hongxiu Fan, Dawei Wang, Hongcheng Liu, Yu Li, Tingting Liu, Shanshan Zhang, Li Wang, Jinfei Chen and Liang Liu and has published in prestigious journals such as Scientific Reports, Small and The Journal of Organic Chemistry.

In The Last Decade

Yuetong Chen

49 papers receiving 796 citations

Hit Papers

Healthy function and high valued utilization of edible fungi 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuetong Chen China 17 257 173 117 106 99 53 809
Siliang Wang China 20 481 1.9× 141 0.8× 141 1.2× 53 0.5× 51 0.5× 61 1.1k
Jinfeng Shi China 18 442 1.7× 133 0.8× 101 0.9× 67 0.6× 56 0.6× 56 1.4k
Ying Ying China 22 530 2.1× 142 0.8× 167 1.4× 111 1.0× 85 0.9× 75 1.5k
Kexin Cao China 19 379 1.5× 113 0.7× 97 0.8× 88 0.8× 74 0.7× 86 1.1k
Md. Nazim Uddin Bangladesh 18 312 1.2× 96 0.6× 112 1.0× 164 1.5× 141 1.4× 143 1.3k
Kaili Wang China 23 388 1.5× 50 0.3× 103 0.9× 81 0.8× 46 0.5× 83 1.4k
Bowen Jiang China 17 424 1.6× 67 0.4× 89 0.8× 39 0.4× 53 0.5× 46 896
Eun Young Bae South Korea 17 390 1.5× 78 0.5× 58 0.5× 48 0.5× 40 0.4× 53 1.0k
Yong Gyu Lee South Korea 26 751 2.9× 185 1.1× 81 0.7× 163 1.5× 119 1.2× 47 1.7k

Countries citing papers authored by Yuetong Chen

Since Specialization
Citations

This map shows the geographic impact of Yuetong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuetong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuetong Chen more than expected).

Fields of papers citing papers by Yuetong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuetong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuetong Chen. The network helps show where Yuetong Chen may publish in the future.

Co-authorship network of co-authors of Yuetong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yuetong Chen. A scholar is included among the top collaborators of Yuetong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuetong Chen. Yuetong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yuetong, et al.. (2025). The impact of the registration system reform on firms’ cross-country investment: Empirical evidence from China. International Review of Economics & Finance. 103. 104440–104440.
2.
Zheng, Weihong, Hualin Xu, Yuetong Chen, et al.. (2025). Optogenetics and Its Application in Nervous System Diseases. Advanced Biology. 9(3). e2400416–e2400416. 1 indexed citations
3.
Hu, Yu, Yuanying Chi, Dunnan Liu, et al.. (2024). Analysis on the synergy between markets of electricity, carbon, and tradable green certificates in China. Energy. 302. 131808–131808. 24 indexed citations
4.
Wang, Nan, Wenhao Yu, Yuetong Chen, Tingting Liu, & Yanrong Zhang. (2024). Study on the rheological and gel properties of Auricularia auricula pulp and konjac glucomannan compound system. Journal of Future Foods. 5(4). 380–387. 3 indexed citations
5.
Sun, Liangliang, et al.. (2024). Siglec15 in blood system diseases: from bench to bedside. Frontiers in Immunology. 15. 1490505–1490505.
6.
Zhang, Min, Zhiming Liu, Ming Shen, et al.. (2023). Ferrostatin-1 attenuates hypoxic-ischemic brain damage in neonatal rats by inhibiting ferroptosis. Translational Pediatrics. 12(11). 1944–1970. 14 indexed citations
7.
Wang, Jing, Xinyue Li, Jing Zhao, et al.. (2023). Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically. Journal of Pharmaceutical Analysis. 13(6). 603–615. 6 indexed citations
8.
Wang, Yanan, et al.. (2023). Effect of arctigenin on neurological diseases: A review. Journal of Ethnopharmacology. 315. 116642–116642. 9 indexed citations
10.
Wang, Qi, Jie Chen, Xinyue Zhang, et al.. (2022). Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma. Frontiers in Immunology. 13. 890150–890150. 21 indexed citations
11.
Wang, Qi, Jie Chen, Xinyue Zhang, et al.. (2022). A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma. Frontiers in Genetics. 13. 862741–862741. 42 indexed citations
12.
Wang, Guijun, et al.. (2022). NADH oxidase of Mycoplasma synoviae is a potential diagnostic antigen, plasminogen/fibronectin binding protein and a putative adhesin. BMC Veterinary Research. 18(1). 455–455. 13 indexed citations
13.
Chen, Yuetong, Cuiju Tang, Xiaowei Wei, et al.. (2020). Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer. Medicine. 99(25). e20809–e20809. 4 indexed citations
15.
Chen, Yuetong, et al.. (2019). Association of microRNA-27a rs895819 polymorphism with the risk of cancer: An updated meta-analysis. Gene. 728. 144185–144185. 7 indexed citations
16.
Shi, Junfeng, Yi Chen, Yuetong Chen, et al.. (2018). Alloreactive cytotoxic T lymphocyte immunotherapy treatment of a patient with metastatic prostate cancer. Medicine. 97(24). e11111–e11111. 4 indexed citations
17.
Wei, Jingsun, Honghong Zhang, Xia Chu, et al.. (2018). Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients. Cancer Management and Research. Volume 10. 1429–1437. 5 indexed citations
18.
Wang, Lei, Liang Liu, Yuetong Chen, et al.. (2018). Correlation between adenosine triphosphate (ATP)-binding cassette transporter G2 (ABCG2) and drug resistance of esophageal cancer and reversal of drug resistance by artesunate. Pathology - Research and Practice. 214(9). 1467–1473. 17 indexed citations
19.
Chen, Yuetong, et al.. (2018). Effects of long noncoding RNA (linc-VLDLR) existing in extracellular vesicles on the occurrence and multidrug resistance of esophageal cancer cells. Pathology - Research and Practice. 215(3). 470–477. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026